Denise E Kirschner, PhD

Denise E. Kirschner
Professor of Microbiology and Immunology
Medical School
University of Michigan
Microbiology and Immunology
1150 W. Medical Center Drive, 6730 MedSci II
Ann Arbor, MI 48109
[email protected]
Available to mentor
Denise E Kirschner, PhD
Denise E. Kirschner
Professor
  • About
  • Links
  • Qualifications
  • Center Memberships
  • Research Overview
  • Recent Publications
  • Manage Your Profile

  • About

    Dr. Kirschner is a professor in the department of Microbiology and Immunology at the University of Michigan. She received her Bachelors, Masters and PhD in applied mathematics from Tulane University. She did graduate work also at Los Alamos National Labs and a postdoctoral fellowship at Vanderbilt University joint with the departments of Mathematics and Infectious Diseases. For the past 25 years, her research focus has been on building multi-scale models to describe the host immune response to M. tuberculosis at multiple spatial and time scales and in multiple physiological sites including lung, lymph nodes and blood. To date she has worked and collaborated with experimentalists generating data on TB with mouse, non-human primate and human studies. Dr. Kirschner currently serves (and has for the past 20 years) as Editor-in-Chief of the Journal of Theoretical Biology. She serves as the founding co-director of The Center for Systems Biology at the University of Michigan, an interdisciplinary center at the University of Michigan aimed to facilitate research and training between wet-lab and theoretical scientists.

    Links

    • Denise Kirschner Home Page
    • Kirschner Lab

    Qualifications

    • Postdoctoral Fellow
      Vanderbilt University Medical Center, Mathematical Modeling, Nashville, United States
      1991 - 1994
      Postdoctoral Fellowship
    • PhD
      Tulane University, New Orleans, LA, United States
      1988 - 1991
    • MS
      Tulane University, New Orleans, LA, United States
      1985 - 1988
    • BS
      Tulane University, New Orleans, LA, United States
      1981 - 1985

    Center Memberships

    • Center Member
      Center for Computational Medicine and Bioinformatics

    Research Overview

    The work in my laboratory focuses mainly on questions related to host-pathogen interactions in infectious diseases. This means defining both the immune responses and the microbial characteristics that lead to infection and disease. In particular, our main focus is studying persistent infections - infections that the host is not able to clear. The persistent pathogens we focus on include both bacteria (e.g. Helicobacter pylori and Mycobacterium tuberculosis) and HIV-1. Such pathogens have evolved strategies to evade or circumvent the host-immune response and our goal is to understand the complex dynamic involved in host-pathogen interactions, together with how perturbations to this interaction (via treatment with chemotherapies or immunotherapies) can lead to prolonged or permanent health of the patient. Drug-resistance and the effects of treatment can be efficiently studied in this setting.

    Currently, our research focus is on the role of the host response in pathogenesis at multiple spatial and time scales. The grants funding our work aim to examine the immune responses in the lymph nodes and lung also during TB infection. There are unique structures, granulomas, which are involved in the immune response to M. tuberculosis and we are developing methods to better understand their formation and function. This data could have a profound impact on our understanding the different disease trajectories seen in patients infected with persistent pathogens.

    We apply a range of computational tools from deterministic mathematical models to more discrete stochastic ones such as Agent Based Models and PDEs to examine spatial questions as well. We are focused on not only building multi-scale models, as that is key to studying these more complex biological systems but using them to study large open-questions related to biomarker discovery, treatment and vaccine development and testing.

    Recent Publications

    See All Publications
    • Journal Article
      A NOVEL MACHINE-LEARNING BASED OPTIMIZATION: IDENTIFYING NEW TREATMENT REGIMENS FOR TUBERCULOSIS
      Budak M, Nanda P, Kirschner D. Numerical Algebra Control and Optimization, 2026 Jan 1; 18: 116 - 145. DOI:10.3934/naco.2025025
    • Journal Article
      The immunometabolic topography of cellular organization and bacterial control in tuberculosis granulomas
      McCaffrey EF, Delmastro AC, Fitzhugh I, Ranek JS, Douglas S, Peters JM, Fullaway CC, Bosse M, Liu CC, Gillen C, Greenwald NF, Anzick S, Martens C, Winfree S, Bai Y, Sowers C, Goldston M, Kong A, Boonrat P, Bigbee CL, Venugopalan R, Maiello P, Klein E, Rodgers MA, Scanga CA, Lin PL, Bendall SC, Kirschner DE, Fortune SM, Bryson BD, Butler JR, Mattila JT, Flynn JAL, Angelo M. Nature Immunology, 2026 Jan 1; DOI:10.1038/s41590-026-02431-8
      PMID: 41731147
    • Journal Article
      Religious and culturally conscious sleep care for Muslim patients: Clinical considerations and recommendations
      Irfan B, Attarian H, Irfan M, Sankari A, Kirschner D, Khan M. Sleep Medicine Reviews, 2025 Oct 1; 83: DOI:10.1016/j.smrv.2025.102138
      PMID: 40737804
    • Journal Article
      Rankings of tuberculosis antibiotic treatment regimens are sensitive to spatial scale, detection limit, and initial host bacterial burden
      Michael CT, Budak M, Maiello P, Kracinovsky K, Rodgers M, Tomko J, Lin PL, Flynn JA, Linderman JJ, Kirschner D. Journal of Theoretical Biology, 2025 Aug 21; 611: DOI:10.1016/j.jtbi.2025.112176
      PMID: 40460906
    • Journal Article
      Distinguishing multiple roles of T cell and macrophage involvement in determining lymph node fates during Mycobacterium tuberculosis infection
      Krupinsky KC, Michael CT, Nanda P, Mattila JT, Kirschner D. Plos Computational Biology, 2025 May 1; 21 (5 May): DOI:10.1371/journal.pcbi.1013033
      PMID: 40334195
    • Preprint
      Rankings of tuberculosis antibiotic treatment regimens are sensitive to spatial scale, detection limit, and initial host bacterial burden
      Michael CT, Budak M, Maiello P, Kracinovsky K, Rodgers M, Tomko J, Lin PL, Flynn J, Linderman JJ, Kirschner D. 2025 Apr 21; bioRxiv, DOI:10.1101/2025.04.10.648004
    • Journal Article
      GEODE: an in silico tool that translates in vitro to in vivo predictions of tuberculosis antibiotic combination efficacy
      Budak M, Moraes MP, Greenstein T, Maiello P, Borish HJ, Chishti HB, Kracinovsky K, Rodgers M, Tomko J, Lin PL, Flynn JAL, Aldridge BB, Kirschner D. Frontiers in Pharmacology, 2025 Jan 1; 16: DOI:10.3389/fphar.2025.1639673
    • Journal Article
      Forum on immune digital twins: a meeting report
      Laubenbacher R, Adler F, An G, Castiglione F, Eubank S, Fonseca LL, Glazier J, Helikar T, Jett-Tilton M, Kirschner D, Macklin P, Mehrad B, Moore B, Pasour V, Shmulevich I, Smith A, Voigt I, Yankeelov TE, Ziemssen T. Npj Systems Biology and Applications, 2024 Dec 1; 10 (1): DOI:10.1038/s41540-024-00345-5
      PMID: 38365857

    Featured News & Stories

    Adam Hafner and Katy Krupinsky
    Department News

    Adam Hafner and Katy Krupinsky receive Rackham Predoctoral Fellowships

    Two Microbiology & Immunology PhD students – Adam Hafner and Katy Krupinsky – are recipients of this year’s Rackham Predoctoral Fellowships.
    DATA Center 2025 spring meeting - Dr Najarian
    Department News

    DATA for drug discovery and treatment assessment: DATA Center 2025 Spring Meeting

    On April 10, 2025, the Center for Data-Driven Drug Development and Treatment Assessment (DATA), an NSF Industry-University Cooperative Research Center (IUCRC), held its third Spring meeting, in Ann Arbor, MI. Hosted at the University of Michigan (U-M), DATA creates and fosters scientific partnerships between industry, government, and academia, focusing on drug discovery that is based on data and tools such as modeling, AI and machine learning.
    Kirschner, Lauring and Martens elected into the AAM
    Department News

    Three M&I Faculty were elected into the American Academy of Microbiology

    U-M microbiology and immunology professors Denise Kirschner, Ph.D., Adam Lauring, M.D., Ph.D., and Eric Martins, Ph.D.  were recently elected as Fellows of the American Academy of Microbiology. These elections further demonstrate the excellence of the U-M Department of Microbiology and Immunology.